Heplisav-b 20 MCG/0.5 ML syrng 0.5ML
Ended Awarded Last action
- Contract number
- SPE2DR26F57DU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $53,228
Award facts
- Contract value 100% obligated
- $53,227.50 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a $53,227.50 firm fixed-price delivery order to AmerisourceBergen Drug Corp on January 7, 2026, for the supply of HEPLISAV-B 20 MCG/0.5 ML syringes. The contract, which carries no set-aside designation, is scheduled for completion by January 8, 2026, and will be performed at the awardee's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a small task order under AmerisourceBergen's parent company Cencora, Inc.'s significant Indefinite Delivery Contract with DLA Troop Support Medical, valued at $999,999,999.00 through December 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to military healthcare systems globally.
HEPLISAV-B is a hepatitis B vaccine indicated for immunization of adults aged 18 and older. The delivery of this vaccine through the DLA supply chain supports military treatment facilities and military healthcare programs. AmerisourceBergen Drug Corp, as the child entity of parent company Cencora, Inc., has demonstrated consistent capability in competing on a full and open basis for federal pharmaceutical procurement requirements, delivering a diverse array of medications and medical supplies across multiple therapeutic domains to support Department of Defense healthcare operations and other federal medical institutions.
Quick answers
Who was awarded contract SPE2DR26F57DU?
SPE2DR26F57DU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on January 7, 2026.
How much is contract SPE2DR26F57DU worth?
The government has obligated $53,228 on SPE2DR26F57DU.
Is contract SPE2DR26F57DU an order under another contract?
Yes. SPE2DR26F57DU is a delivery order under SPE2DR25D2006, an indefinite delivery contract.
Was contract SPE2DR26F57DU competed?
The extent of competition for SPE2DR26F57DU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award